Hutch News
Search and Filter
An old HIV vaccine surprises researchers once again
Designed for a Thailand strain of the AIDS virus, it stirred stronger immunity in South Africa
Mystery solved: How graft-vs.-host disease starts in the gut
Microbiome triggers top killer after bone marrow transplant — and there’s a potential way to stop it
Fred Hutch President and Director Dr. Gary Gilliland announces plan to step down
5 years of leadership reinforced Fred Hutch scientific excellence, collaborative research, partnerships and financial strength
Former WSJ health columnist tells her story of cancer survival
After treatment at Fred Hutch, Laura Landro inspired to empower patients via health and medicine journalism
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 16, 2019
Dr. Zhe Ying receives award to study how head and neck cancers overcome newly discovered tumor-blocking mechanism
Postdoc’s Pathway to Independence Award will help lay the foundation for his early career
Cancer patients find clinical trials, hope and help
#NWMetsConf connects metastatic breast cancer patients with trials, treatments, tools and each other
New type of viral anti-CRISPR found in human microbiome
Protein used by viruses to combat DNA-snipping action of bacterias’ CRISPR immune system
The link between baby’s cells and mom’s disease risk
Why does mom’s risk for rheumatoid arthritis skyrocket when her baby has a gene that protects against it?
3 cancers, 2 women, 1 goal
A patient and caregiver bond over their shared diagnosis, lust for adventure and quest to cure the ‘harder cancers’
Nanotech turns pro-tumor immune cells into cancer-killing triple agents
Strategy doubles survival in mice with cancer
Life Sciences Research Foundation funds study to track evolution, spread of bird flu
Computational biologist and virologist Dr. Louise Moncla receives 3-year grant
Dr. Cameron Turtle receives Anderson Family Endowed Chair for Immunotherapy
Gift will ‘help new ideas move rapidly toward the patients who need them’
Scientists gather in Seattle to share strategies for an HIV cure
Workshop focuses on ways to lower cost, broaden reach of gene therapy
Why does flu make some people sick, but not others?
New study points to single mutations that allow flu to slip past immune system of some people, but not others
Conference on gene therapy for HIV cures will highlight progress and challenges ahead
Dr. Robert Siliciano, keynote speaker, discovered why AIDS drugs alone cannot cure HIV
Leukemia researcher Dr. Jerry Radich receives Kurt Enslein Endowed Chair
New chair continues legacy of giving sparked by lifesaving care
Campeona de la ciencia y la justicia social
Una investigadora pionera en salud pública y de gran corazón, la Dra. Beti Thompson, se jubila después de más de 30 años de luchar por la equidad
Remembering Dr. Ron Reeder, molecular biologist-turned-photographer
Renaissance man and expert in gene regulation had enduring impact on Fred Hutch’s Basic Sciences Division
‘Community coming together’: Obliteride raises more than $2.5M for cancer research
Record number of participants register to ride, walk and run for science at Fred Hutch
Two early-career Fred Hutch scientists receive prestigious fellowships for prostate cancer research
Alexandra Corella wins Ford Foundation funding; Sander Frank earns NIH training fellowship
In Uganda: Treating twin threats of HIV and cancer
Dr. Sue Desmond-Hellmann of the Bill & Melinda Gates Foundation visits Hutch researchers in Kampala
New program to fast-track lung cancer research from lab to clinic
Patient-focused science at the heart of $13M National Cancer Institute grant
Remembering transplant immunologist Dr. John Hansen
Physician-scientist defined rules for matching bone marrow transplant donors and patients, was a founding father of volunteer donor registries
Eight promising projects win Evergreen Fund grants to promote commercialization of research
A dozen scientists to receive up to $200K from 3-year-old Fred Hutch program